| Ytd | -38.91% | |
| 1y | -35.84% |
| Open | 1.37 | Prev Close | 1.36 | Low | 1.37 | High | 1.42 | Mkt Cap | 133.19M |
| Vol | 98.84K | Avg Vol | 775.32K | EPS | -0.17 | P/E | -8.00 | Forward P/E | -13.06 |
| Beta | 1.37 | Short Ratio | 6.26 | Inst. Own | 48.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-12 | 50-d Avg | 1.69 | 200-d Avg | 2.10 | 1yr Est | 4.50 |
STXS News
ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global le
First Robotic Magnetic Navigation system installed in Hungary University of Szeged, led by Cardiolog
Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-
ST. LOUIS and ROUEN, France, July 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer a
Stereotaxis NYSEAMERICAN: STXS said its first-quarter results did not yet reflect what management de
Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus
Proprietary robotically-navigated MAGiC catheter received U. S. FDA approval in January and is now b
STXS stock gains after first U.S. MAGiC procedures, marking a key milestone in robotic cardiac care
ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader
ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader
Stereotaxis expands in robotic surgery with Robocath acquisition, aiming to build a comprehensive en
Stereotaxis, Inc. (STXS) M&A Call Transcript
ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer
STXS jumps on FDA clearance of Synchrony system, a 4K platform integrating cath lab tech with cloud
ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader
Stereotaxis targets early-stage endovascular robotics with differentiated magnetic navigation for el
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.06 per share in line with the Zacks Con
